113 related articles for article (PubMed ID: 23375953)
1. Low dose BMP-2 treatment for bone repair using a PEGylated fibrinogen hydrogel matrix.
Ben-David D; Srouji S; Shapira-Schweitzer K; Kossover O; Ivanir E; Kuhn G; Müller R; Seliktar D; Livne E
Biomaterials; 2013 Apr; 34(12):2902-10. PubMed ID: 23375953
[TBL] [Abstract][Full Text] [Related]
2. Osteoblastic bone formation is induced by using nanogel-crosslinking hydrogel as novel scaffold for bone growth factor.
Hayashi C; Hasegawa U; Saita Y; Hemmi H; Hayata T; Nakashima K; Ezura Y; Amagasa T; Akiyoshi K; Noda M
J Cell Physiol; 2009 Jul; 220(1):1-7. PubMed ID: 19301257
[TBL] [Abstract][Full Text] [Related]
3. Silk implants for the healing of critical size bone defects.
Meinel L; Fajardo R; Hofmann S; Langer R; Chen J; Snyder B; Vunjak-Novakovic G; Kaplan D
Bone; 2005 Nov; 37(5):688-98. PubMed ID: 16140599
[TBL] [Abstract][Full Text] [Related]
4. A novel poly(ethylene glycol)-fibrinogen hydrogel for tibial segmental defect repair in a rat model.
Peled E; Boss J; Bejar J; Zinman C; Seliktar D
J Biomed Mater Res A; 2007 Mar; 80(4):874-84. PubMed ID: 17072852
[TBL] [Abstract][Full Text] [Related]
5. A combined cell and growth factor delivery for the repair of a critical size tibia defect using biodegradable hydrogel implants.
Cohen T; Kossover O; Peled E; Bick T; Hasanov L; Chun TT; Cool S; Lewinson D; Seliktar D
J Tissue Eng Regen Med; 2022 Apr; 16(4):380-395. PubMed ID: 35119200
[TBL] [Abstract][Full Text] [Related]
6. The role of matrix metalloproteinases in regulating neuronal and nonneuronal cell invasion into PEGylated fibrinogen hydrogels.
Sarig-Nadir O; Seliktar D
Biomaterials; 2010 Sep; 31(25):6411-6. PubMed ID: 20537384
[TBL] [Abstract][Full Text] [Related]
7. Fabrication of PEGylated fibrinogen: a versatile injectable hydrogel biomaterial.
Mironi-Harpaz I; Berdichevski A; Seliktar D
Methods Mol Biol; 2014; 1181():61-8. PubMed ID: 25070327
[TBL] [Abstract][Full Text] [Related]
8. A comparative analysis of bone formation induced by human demineralized freeze-dried bone and enamel matrix derivative in rat calvaria critical-size bone defects.
Intini G; Andreana S; Buhite RJ; Bobek LA
J Periodontol; 2008 Jul; 79(7):1217-24. PubMed ID: 18597604
[TBL] [Abstract][Full Text] [Related]
9. Growth Factor Delivery for the Repair of a Critical Size Tibia Defect Using an Acellular, Biodegradable Polyethylene Glycol-Albumin Hydrogel Implant.
Kossover O; Cohen N; Lewis JA; Berkovitch Y; Peled E; Seliktar D
ACS Biomater Sci Eng; 2020 Jan; 6(1):100-111. PubMed ID: 33463206
[TBL] [Abstract][Full Text] [Related]
10. Recombinant protein-co-PEG networks as cell-adhesive and proteolytically degradable hydrogel matrixes. Part II: biofunctional characteristics.
Rizzi SC; Ehrbar M; Halstenberg S; Raeber GP; Schmoekel HG; Hagenmüller H; Müller R; Weber FE; Hubbell JA
Biomacromolecules; 2006 Nov; 7(11):3019-29. PubMed ID: 17096527
[TBL] [Abstract][Full Text] [Related]
11. Bone morphogenetic protein-2 enhances bone formation when delivered by a synthetic matrix containing hydroxyapatite/tricalciumphosphate.
Jung RE; Weber FE; Thoma DS; Ehrbar M; Cochran DL; Hämmerle CH
Clin Oral Implants Res; 2008 Feb; 19(2):188-95. PubMed ID: 18067602
[TBL] [Abstract][Full Text] [Related]
12. Effects of recombinant human bone morphogenic protein-2 and human bone marrow-derived stromal cells on in vivo bone regeneration of chitosan-poly(ethylene oxide) hydrogel.
Jo S; Kim S; Cho TH; Shin E; Hwang SJ; Noh I
J Biomed Mater Res A; 2013 Mar; 101(3):892-901. PubMed ID: 23023810
[TBL] [Abstract][Full Text] [Related]
13. Synthetic biodegradable polymers as drug delivery systems for bone morphogenetic proteins.
Saito N; Murakami N; Takahashi J; Horiuchi H; Ota H; Kato H; Okada T; Nozaki K; Takaoka K
Adv Drug Deliv Rev; 2005 May; 57(7):1037-48. PubMed ID: 15876402
[TBL] [Abstract][Full Text] [Related]
14. Repair of bone defects in revision hip arthroplasty by implantation of a new bone-inducing material comprised of recombinant human BMP-2, Beta-TCP powder, and a biodegradable polymer: an experimental study in dogs.
Hoshino M; Namikawa T; Kato M; Terai H; Taguchi S; Takaoka K
J Orthop Res; 2007 Aug; 25(8):1042-51. PubMed ID: 17469187
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo evaluation of adenovirus combined silk fibroin scaffolds for bone morphogenetic protein-7 gene delivery.
Zhang Y; Fan W; Nothdurft L; Wu C; Zhou Y; Crawford R; Xiao Y
Tissue Eng Part C Methods; 2011 Aug; 17(8):789-97. PubMed ID: 21506685
[TBL] [Abstract][Full Text] [Related]
16. Long-term evaluation of bone formation by osteogenic protein 1 in the baboon and relative efficacy of bone-derived bone morphogenetic proteins delivered by irradiated xenogeneic collagenous matrices.
Ripamonti U; Van Den Heever B; Crooks J; Tucker MM; Sampath TK; Rueger DC; Reddi AH
J Bone Miner Res; 2000 Sep; 15(9):1798-809. PubMed ID: 10976999
[TBL] [Abstract][Full Text] [Related]
17. A porcine collagen-derived matrix as a carrier for recombinant human bone morphogenetic protein-2 enhances spinal fusion in rats.
Miyazaki M; Morishita Y; He W; Hu M; Sintuu C; Hymanson HJ; Falakassa J; Tsumura H; Wang JC
Spine J; 2009; 9(1):22-30. PubMed ID: 18805060
[TBL] [Abstract][Full Text] [Related]
18. Addition of human recombinant bone morphogenetic protein-2 to inactive commercial human demineralized freeze-dried bone allograft makes an effective composite bone inductive implant material.
Schwartz Z; Somers A; Mellonig JT; Carnes DL; Wozney JM; Dean DD; Cochran DL; Boyan BD
J Periodontol; 1998 Dec; 69(12):1337-45. PubMed ID: 9926763
[TBL] [Abstract][Full Text] [Related]
19. Optimized use of a biodegradable polymer as a carrier material for the local delivery of recombinant human bone morphogenetic protein-2 (rhBMP-2).
Kato M; Toyoda H; Namikawa T; Hoshino M; Terai H; Miyamoto S; Takaoka K
Biomaterials; 2006 Mar; 27(9):2035-41. PubMed ID: 16256191
[TBL] [Abstract][Full Text] [Related]
20. Analysis of hydrolyzable polyethylene glycol hydrogels and deproteinized bone mineral as delivery systems for glycosylated and non-glycosylated bone morphogenetic protein-2.
Hänseler P; Jung UW; Jung RE; Choi KH; Cho KS; Hämmerle CH; Weber FE
Acta Biomater; 2012 Jan; 8(1):116-23. PubMed ID: 21867781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
